Tycho Peterson
Stock Analyst at Jefferies
(5.00)
# 2
Out of 4,944 analysts
131
Total ratings
66.3%
Success rate
164.03%
Average return
Main Sectors:
Stocks Rated by Tycho Peterson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Buy | $435 → $385 | $296.83 | +29.70% | 8 | Aug 4, 2025 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $155 | $120.29 | +28.86% | 8 | May 29, 2025 | |
| WGS GeneDx Holdings | Upgrades: Buy | $80 | $123.11 | -35.02% | 1 | May 9, 2025 | |
| QDEL QuidelOrtho | Upgrades: Buy | $44 | $27.08 | +62.48% | 6 | May 8, 2025 | |
| MTD Mettler-Toledo International | Upgrades: Hold | $1,200 → $1,100 | $1,324.06 | -16.92% | 8 | May 5, 2025 | |
| DHR Danaher | Maintains: Overweight | $280 → $260 | $209.14 | +24.32% | 3 | Apr 22, 2025 | |
| LH Labcorp Holdings | Maintains: Buy | $275 → $290 | $272.54 | +6.41% | 2 | Feb 6, 2025 | |
| NEO NeoGenomics | Initiates: Buy | $22 | $6.24 | +252.56% | 1 | Dec 10, 2024 | |
| DGX Quest Diagnostics | Assumes: Buy | $185 | $179.04 | +3.33% | 1 | Dec 10, 2024 | |
| HOLX Hologic | Initiates: Hold | $85 | $68.98 | +23.22% | 7 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $43 → $56 | $49.23 | +12.98% | 5 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $35 | $28.65 | +22.16% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $115 → $125 | $90.93 | +37.47% | 1 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $13.57 | +76.86% | 7 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.28 | +212.50% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $5 → $3 | $0.72 | +319.46% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $142 | $157.70 | -9.96% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $58.57 | -45.36% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $115 | $101.11 | +13.74% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Underperform | $25 → $20 | $5.87 | +240.72% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $600 → $650 | $484.79 | +34.08% | 12 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $26 → $9 | $15.72 | -42.75% | 1 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.91 | - | 2 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 → $12 | $2.17 | +453.00% | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $60 | $4.79 | +1,152.61% | 2 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $3.11 | +639.55% | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $375 → $390 | $155.00 | +151.61% | 5 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $2.85 | +531.58% | 1 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $188 → $200 | $482.35 | -58.54% | 9 | Jun 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $24 | $21.56 | +11.32% | 3 | Jun 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $65 → $45 | $13.85 | +224.91% | 5 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $70 | $127.15 | -44.95% | 2 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $120 | $190.23 | -36.92% | 1 | Feb 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $1.49 | - | 7 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $34.54 | - | 5 | Nov 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $55 | $14.25 | +285.96% | 1 | Jul 19, 2016 |
Waters
Aug 4, 2025
Maintains: Buy
Price Target: $435 → $385
Current: $296.83
Upside: +29.70%
Agilent Technologies
May 29, 2025
Maintains: Overweight
Price Target: $160 → $155
Current: $120.29
Upside: +28.86%
GeneDx Holdings
May 9, 2025
Upgrades: Buy
Price Target: $80
Current: $123.11
Upside: -35.02%
QuidelOrtho
May 8, 2025
Upgrades: Buy
Price Target: $44
Current: $27.08
Upside: +62.48%
Mettler-Toledo International
May 5, 2025
Upgrades: Hold
Price Target: $1,200 → $1,100
Current: $1,324.06
Upside: -16.92%
Danaher
Apr 22, 2025
Maintains: Overweight
Price Target: $280 → $260
Current: $209.14
Upside: +24.32%
Labcorp Holdings
Feb 6, 2025
Maintains: Buy
Price Target: $275 → $290
Current: $272.54
Upside: +6.41%
NeoGenomics
Dec 10, 2024
Initiates: Buy
Price Target: $22
Current: $6.24
Upside: +252.56%
Quest Diagnostics
Dec 10, 2024
Assumes: Buy
Price Target: $185
Current: $179.04
Upside: +3.33%
Hologic
Dec 10, 2024
Initiates: Hold
Price Target: $85
Current: $68.98
Upside: +23.22%
Dec 10, 2024
Assumes: Buy
Price Target: $43 → $56
Current: $49.23
Upside: +12.98%
Aug 5, 2024
Maintains: Underweight
Price Target: $28 → $35
Current: $28.65
Upside: +22.16%
Jul 29, 2024
Maintains: Hold
Price Target: $115 → $125
Current: $90.93
Upside: +37.47%
Jul 22, 2024
Upgrades: Buy
Price Target: $24
Current: $13.57
Upside: +76.86%
Jun 3, 2024
Initiates: Buy
Price Target: $4
Current: $1.28
Upside: +212.50%
Jun 3, 2024
Assumes: Hold
Price Target: $5 → $3
Current: $0.72
Upside: +319.46%
Jun 3, 2024
Initiates: Buy
Price Target: $142
Current: $157.70
Upside: -9.96%
Jun 3, 2024
Initiates: Buy
Price Target: $32
Current: $58.57
Upside: -45.36%
Jun 3, 2024
Assumes: Hold
Price Target: $115
Current: $101.11
Upside: +13.74%
Jun 3, 2024
Assumes: Underperform
Price Target: $25 → $20
Current: $5.87
Upside: +240.72%
Jun 3, 2024
Assumes: Buy
Price Target: $600 → $650
Current: $484.79
Upside: +34.08%
Sep 21, 2022
Downgrades: Underweight
Price Target: $26 → $9
Current: $15.72
Upside: -42.75%
Aug 16, 2022
Downgrades: Neutral
Price Target: n/a
Current: $2.91
Upside: -
Aug 11, 2022
Downgrades: Neutral
Price Target: $20 → $12
Current: $2.17
Upside: +453.00%
Mar 2, 2022
Maintains: Overweight
Price Target: $85 → $60
Current: $4.79
Upside: +1,152.61%
Aug 17, 2021
Initiates: Overweight
Price Target: $23
Current: $3.11
Upside: +639.55%
May 28, 2021
Maintains: Overweight
Price Target: $375 → $390
Current: $155.00
Upside: +151.61%
Aug 10, 2020
Initiates: Neutral
Price Target: $18
Current: $2.85
Upside: +531.58%
Jun 18, 2020
Maintains: Overweight
Price Target: $188 → $200
Current: $482.35
Upside: -58.54%
Jun 1, 2020
Maintains: Overweight
Price Target: $22 → $24
Current: $21.56
Upside: +11.32%
Mar 17, 2020
Maintains: Neutral
Price Target: $65 → $45
Current: $13.85
Upside: +224.91%
Nov 2, 2018
Maintains: Overweight
Price Target: $60 → $70
Current: $127.15
Upside: -44.95%
Feb 15, 2018
Maintains: Overweight
Price Target: $115 → $120
Current: $190.23
Upside: -36.92%
Dec 13, 2017
Downgrades: Underweight
Price Target: n/a
Current: $1.49
Upside: -
Nov 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $34.54
Upside: -
Jul 19, 2016
Initiates: Neutral
Price Target: $55
Current: $14.25
Upside: +285.96%